Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 7/20 | 0.79 |
| ▸ | PTGS2 | P35354 | 13/20 | 0.74 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2695601 | 0.95 | PTGS1 (0.80) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL3276806 | 0.95 | PTGS1 (0.79) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL22289006 | 0.94 | PTGS1 (0.71) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL18448495 | 0.88 | PTGS1 (1.00) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL3277724 | 0.87 | PTGS1 (0.68) | PTGS1PTGS2PDPK1MAPTCYP2C9 | |
| SCHEMBL17077240 | 0.87 | PTGS1 (0.80) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL5698545 | 0.87 | PTGS1 (0.80) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL5430134 | 0.87 | PTGS1 (0.80) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL31543731 | 0.87 | PTGS1 (0.80) | PTGS1PTGS2PDPK1CYP2C9 | |
| SCHEMBL2697786 | 0.86 | PTGS1 (0.78) | PTGS1PTGS2PDPK1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595486-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-07 | — | — | US | disclosed |
| US-12584137-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12584136-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12584135-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | disclosed |
| US-12359205-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-15 | — | — | US | disclosed |
| WO-2025099444-A1 | N-Acetylserotonin (NAS) Analogues | Beckley Psytech Limited (GB) | 2025-05-15 | — | — | WO | disclosed |
| US-12171203-B2 | Transgenic biosensor | NEMAMETRIX INC. (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240209375-A1 | Aptamers For Personal Health Care Applications | PROCTER & GAMBLE (US) | 2024-06-27 | — | — | US | disclosed |
| US-11859187-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220135664-A1 | Use of an antibody and antisense in the treatment of Congenital Muscular Dystrophy | University of Zagreb School of Medicine (HR) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584136-B2 | Aptamers for personal health care applications | HAVCR2, LDLR, ICAM1 | PTGS1 4645/4885PTGS2 4837/4885PDPK1 3215/4885 |
| US-12584135-B2 | Aptamers for personal health care applications | ICAM1, VCAM1, EPCAM | PTGS1 4712/4885PTGS2 4874/4885PDPK1 3318/4885 |
| US-12595486-B2 | Aptamers for personal health care applications | HAVCR2, EPCAM, ICAM1 | PTGS1 4706/4885PTGS2 4850/4885PDPK1 2455/4885 |
| US-12584137-B2 | Aptamers for personal health care applications | HAVCR2, LDLR, ICAM1 | PTGS1 4737/4885PTGS2 4850/4885PDPK1 3340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.